
Roflumilast Foam Effective for Scalp and Body Psoriasis
TOPLINE: Once-daily 0.3% topical roflumilast foam significantly reduced severity in patients with psoriasis of the scalp and body over 8 weeks, with a favorable safety profile. METHODOLOGY: Researchers conducted phase 3 double-blinded, randomized ARRECTOR …